Cantitate/Preț
Produs

Designs for Clinical Trials: Perspectives on Current Issues: Applied Bioinformatics and Biostatistics in Cancer Research

Editat de David Harrington
en Limba Engleză Paperback – 29 noi 2013
This book will examine current issues and controversies in the design of clinical trials, including topics in adaptive and sequential designs, the design of correlative genomic studies, the design of studies in which missing data is anticipated.  Each chapter will be written by an expert conducting research in the topic of that chapter.  As a collection, the chapters would be intended to serve as a guidance for statisticians designing trials.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 109004 lei  6-8 săpt.
  Springer – 29 noi 2013 109004 lei  6-8 săpt.
Hardback (1) 109935 lei  6-8 săpt.
  Springer – 8 oct 2011 109935 lei  6-8 săpt.

Din seria Applied Bioinformatics and Biostatistics in Cancer Research

Preț: 109004 lei

Preț vechi: 114741 lei
-5% Nou

Puncte Express: 1635

Preț estimativ în valută:
20867 21473$ 17590£

Carte tipărită la comandă

Livrare economică 01-15 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461429531
ISBN-10: 1461429536
Pagini: 220
Ilustrații: XIV, 206 p.
Dimensiuni: 155 x 235 x 12 mm
Greutate: 0.31 kg
Ediția:2012
Editura: Springer
Colecția Springer
Seria Applied Bioinformatics and Biostatistics in Cancer Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

New designs for phase I dose finding studies.- Phase II/III designs for trials.- Design issues for clinical studies with genomic measurements.- Designing studies with longitudinal measurements subject to dropout.- Issues in sample size re-estimation.- Adaptive designs.- The design of non-inferiority trials.- Issues in the design of HIV prevention trials.- Randomization algorithms.- Sequential designs for phase III studies.- Case studies of difficult designs.- Ethical issues in the design of trials.- Index.

Recenzii

From the reviews:
“‘Designs for Clinical Trials: Perspectives on Current Issues’ fills the gap between professional journals and school textbooks by addressing a few important, rapidly evolving statistical topics. The book is intended for statistical practitioners like clinical trialists who actively use statistics but do not follow the literature on recent biostatistical thinking.” (Norman M. Goldfarb, Journal of Clinical Research Best Practices, Vol. 9 (2), February, 2013)

Textul de pe ultima copertă

Statistical methods for clinical trials have been an area of active research in Biostatistics since the first modern clinical trials were mounted in 1946 by the British Medical Research Council in whooping cough and tuberculosis.  Often, the participants in clinical trials suffer from potentially fatal chronic diseases, and it is especially important that these experiments in medical research use designs that are efficient, can be understood by physicians, policy makers and patients, respond quickly new ideas in medicine and statistics, and, perhaps above all, show respect for the complex and important ethical issues that arise in these settings.
 
This book explores some recent thinking in designs for clinical trials, including alternative designs for phase I studies, interim monitoring for futility, adaptive designs based on accumulating outcome data, and designs of new, targeted therapies.  The book is intended for both the statistical practitioner, who may be too busy to stay abreast of the literature on statistical methods, as well as statisticians conducting research in clinical trials.

Caracteristici

Each chapter will be written by an expert conducting research in the topic of that chapter. This book examines current issues and controversies in the design of clinical trials, including topics in adaptive and sequential designs, the design of correlative genomic studies, and the design of studies in which missing data is anticipated. The chapters serve as a guidance for statisticians designing trials.